Ventana Medical Systems, Inc.

Ventana Medical Systems, Inc., together with its subsidiaries, engages in the development, manufacture, and marketing of instrument-reagent systems that automate slide staining in anatomical pathology and drug discovery laboratories. Its clinical systems are used in anatomical pathology labs in analyzing human tissue to assist in the diagnosis and treatment of cancer and infectious diseases. The company’s drug discovery systems are used by pharmaceutical and biotechnology companies to increase the discovery of new drug targets and to evaluate the safety of new drug compounds. It also markets consumable products, including reagents and other accessories. The company’s products are used in H&E staining, Immunohistochemistry (IHC) staining, In situ hybridization (ISH) staining, and Special Stains staining. It serves hospital-based anatomical pathology labs, independent reference labs, the drug discovery labs of pharmaceutical companies, biotechnology companies, government labs, medical research centers, and resellers serving these entities. Ventana Medical operates in the United States, France, Germany, the United Kingdom, Japan, and Australia. The company was founded in 1985 and is headquartered in Tucson, Arizona.